Related Experiment Video
Updated: May 14, 2026

03:08
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Drug target inference through pathway analysis of genomics data
1Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511, USA. haisu.ma@yale.edu
Advanced Drug Delivery Reviews
|February 2, 2013
Summary
This review covers computational drug discovery using pathway analysis of genomics data. It explores system-level pharmacology and target inference methods for future research directions.
Area of Science:
- Bioinformatics
- Computational Biology
- Pharmacology
Background:
- Statistical modeling and bioinformatics are key in drug discovery.
- A shift towards system-level pharmacology is evident.
- Pathway analysis of genomics data offers a promising avenue for target inference.
Purpose of the Study:
- To provide a comprehensive review of computational drug target inference.
- To cover methodological developments in pathway analysis for drug discovery.
- To discuss the pros and cons of current approaches and future research directions.
Main Methods:
- Review of existing literature on pathway analysis in drug discovery.
- Analysis of methodological advancements in computational target inference.
- Discussion of system-level pharmacological research approaches.
Main Results:
- Identification of key trends in computational drug discovery.
- Evaluation of various pathway analysis techniques for target identification.
- Summary of challenges and opportunities in the field.
Conclusions:
- Pathway analysis of genomics data is a critical component of modern drug discovery.
- System-level approaches are essential for advancing pharmacological research.
- Further research is needed to refine computational methods for drug target inference.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...

